Renal cancer is a common malignancy of the urinary system. For localized and locally advanced renal cancer without distant or extraregional lymph node metastases, surgical removal of the tumor or the affected kidney remains the primary treatment. Recent advances in targeted therapy and immunotherapy have expanded the options for perioperative treatment of renal cancer. In 2024, this field saw significant breakthroughs, and Dr. Liangyou Gu from the Chinese PLA General Hospital shared the latest research developments.

From November 14 to 17, 2024, the Cellular Therapy and Immunotherapy Conference (CTI) was held in Hangzhou, China, bringing together global experts, scholars, and industry leaders in cellular and immunotherapy.…

Editor’s Note: As precision medicine continues to advance, breakthroughs in immunotherapy and the development of personalized treatment strategies are ushering in an exciting new era for lung cancer treatment. On…

The "Northern Breast Cancer Salon Annual Progress Review" was held in Beijing from January 3 to 5, 2025, providing a comprehensive overview of the latest developments in the diagnosis, treatment, and research of breast cancer over the past year. Dr. Shusen Wang from the Sun Yat-sen University Cancer Center presented a summary of the advances in endocrine therapy for advanced breast cancer in 2024. After the conference, Oncology Frontier invited Professor Wang for an in-depth interpretation of these significant developments.